Moreover, in the present study we confirmed our previous data, showing that JNK and its target p38 are pivotal factors in the regulation of cell proliferation and apoptosis in HCC cells treated with Regorafenib [32]. The gene discussed is MAPK8; the disease is hepatocellular carcinoma.